SCHEMBL3404040

SCHEMBL3404040

O=C(CO)Oc1ccc(Cc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.54
PPARA Q07869 3/20 0.54
CYP19A1 P11511 1/20 0.53
KMT2A Q03164 4/20 0.51
HPGD P15428 2/20 0.51
LTA4H P09960 2/20 0.50
SRD5A2 P31213 1/20 0.50
ASAH1 Q13510 1/20 0.49
ELANE P08246 1/20 0.49
PLA2G10 O15496 1/20 0.47
PLA2G2A P14555 1/20 0.47
LMNA P02545 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
MGLL Q99685 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9737769 0.87 LTA4H (0.52) PPARGPPARACYP19A1KMT2AHPGD
SCHEMBL593272 0.84 CYP19A1 (0.58) CYP19A1KMT2AHPGDASAH1ELANE
SCHEMBL5478152 0.82 LTA4H (0.55) PPARGPPARALTA4HSRD5A2ELANE
SCHEMBL6224844 0.82 LTA4H (0.55) PPARGPPARALTA4HSRD5A2ELANE
Malonic Acid SCHEMBL8752798 0.82 LTA4H (0.49) PPARGPPARACYP19A1KMT2AHPGD
SCHEMBL27396289 0.82 CYP19A1 (0.56) CYP19A1KMT2AHPGDELANELMNA
SCHEMBL1931453 0.82 KMT2A (0.54) CYP19A1KMT2AHPGDELANELMNA
SCHEMBL8060201 0.81 SRD5A2 (0.58) PPARGPPARACYP19A1LTA4HSRD5A2
SCHEMBL7564565 0.81 ASAH1 (0.55) PPARGPPARACYP19A1KMT2AASAH1
SCHEMBL538524 0.80 CYP19A1 (0.76) CYP19A1KMT2AHPGDASAH1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10675278-B2 Crush resistant delayed-release dosage forms Grünenthal GmbH (DE) 2020-06-09 US disclosed
US-20180369235-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2018-12-27 US disclosed
US-20170312271-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2017-11-02 US disclosed
US-9750701-B2 Pharmaceutical dosage form Grünenthal GmbH (DE) 2017-09-05 US disclosed
US-20160199305-A1 PHARMACEUTICAL DOSAGE FORM Grünenthal GmbH (DE) 2016-07-14 US disclosed
US-20160184297-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2016-06-30 US disclosed
US-20160120810-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2016-05-05 US disclosed
US-20150374630-A1 Crush resistant delayed-release dosage forms GRUENENTHAL GMBH (DE) 2015-12-31 US disclosed
US-20150290138-A1 Crush resistant delayed-release dosage forms Grünenthal GmbH (DE) 2015-10-15 US disclosed
US-20140322323-A1 PHARMACEUTICAL DOSAGE FORM Grünenthal GmbH (DE) 2014-10-30 US disclosed
US-20140322311-A1 CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM Grünenthal GmbH (DE) 2014-10-30 US disclosed
US-20140079780-A1 Crush resistant delayed-release dosage forms GRUENENTHAL GMBH (DE) 2014-03-20 US disclosed
US-20130251759-A1 PHARMACEUTICAL DOSAGE FORM GRUENENTHAL GMBH (DE) 2013-09-26 US disclosed
US-8383152-B2 Pharmaceutical dosage form GRUENENTHAL GMBH (DE) 2013-02-26 US disclosed
EP-2249811-A1 PHARMACEUTICAL DOSAGE FORM Grünenthal GmbH (DE) 2010-11-17 EP disclosed
US-20100151028-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS GRUNENTHAL GMBH (DE) 2010-06-17 US disclosed
US-20090202634-A1 PHARMACEUTICAL DOSAGE FORM GRUNENTHAL GMBH (DE) 2009-08-13 US disclosed
WO-2009092601-A1 PHARMACEUTICAL DOSAGE FORM Grünenthal GmbH (DE) 2009-07-30 WO disclosed
US-20080311187-A1 CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM GRUNENTHAL GMBH (DE) 2008-12-18 US disclosed
US-20060193914-A1 Crush resistant delayed-release dosage forms ENDO PHARMACEUTICALS, INC. 2006-08-31 US disclosed